LONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER

This publication has 28 references indexed in Scilit:

• A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder
  New England Journal of Medicine, 1991
• Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.
  Journal of Clinical Oncology, 1988
• Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)
  BMJ, 1988
• Recurrence, Progression and Survival in Bladder Cancer
  Scandinavian Journal of Urology and Nephrology, 1987
• The Effect of Intravesical Thiotepa on the Recurrence Rate of Newly Diagnosed Superficial Bladder Cancer. An MRC Study
  British Journal of Urology, 1985
• Prophylactic Chemotherapy of Superficial Transitional Cell Bladder Carcinoma: an EORTC Randomized Trial Comparing Thiotepa, an Epipodophyllotoxin (VM26) and TUR Alone
  European Urology, 1982
• The Correlation of TI Bladder Tumour History with Prognosis and Follow-up Requirements
  British Journal of Urology, 1981
• Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer
  Urology, 1977
• Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder Carcinoma
  British Journal of Urology, 1976
• REPORT OF A FOLLOW-UP OF PAPILLARY TUMOURS OF THE BLADDER1
  British Journal of Urology, 1964